A recently developed blood test has the capability to anticipate the presence of Alzheimer’s disease in individuals even before symptoms become apparent.
The research, as detailed in the Journal of the American Medical Association (JAMA) Neurology, highlights that the test identifies specific proteins that accumulate in individuals affected by the disease.
Unlike existing methods involving brain scans or spinal taps, which can be logistically challenging, this innovative blood test demonstrated comparable accuracy. While currently limited to research purposes, experts anticipate its potential availability for clinical use in the near future.